While 1 in 5 Americans say they have a food allergy, 1 in 10 actually do; a patient with a rare form of brain cancer is the first patient to be treated under the Right to Try Law; and federal data show significant variation in fertility rates around the country.
While 1 in 5 Americans say they have a food allergy, many of them probably don’t, according to a study published in JAMA Network Open. Researchers surveyed over 40,000 adults and found that, although 19% of adults reported a food allergy, estimated food allergy prevalence among US adults is actually 10.8%, corresponding with more than 26 million adults. The most common allergy was shellfish, followed by milk, peanuts, tree nuts, fin fish, eggs, wheat, soy, and sesame.
A patient with an aggressive form of brain cancer has become the first patient in the United States to receive experimental treatment under the Right to Try law of 2017. After failing to qualify for clinical trial enrollment, the patient started receiving the experimental treatment ERC-1671 at the University of California, Irvine in November 2018, reported RAPS. The treatment is in phase 2 clinical trials.As the birthrate in the United States continues to decline, a new look at federal data has found significant variation in fertility rates around the country. States in the Midwest and Southeast have higher rates of fertility compared with the Northeast and West Coast. According to The Wall Street Journal, in 2017, there was a 57% difference between the highest state rate (South Dakota, 2227 births) and the lowest (District of Columbia, 1421 births). Hispanic women had the highest fertility rate of the ethnicities studied.
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
Use of AI Lets Health System Find Lung Cancer at Early Stages
March 8th 2025Artificial intelligence (AI) helps a Sarasota, Florida, health system catch lung nodules that appear on CT scans for patients treated for scores of conditions, allowing them to be referred for a possible lung cancer diagnosis.
Read More
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen